{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T10:56:52Z","timestamp":1770548212359,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005632","name":"Forest Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.neuropharm.2016.03.045","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T04:19:36Z","timestamp":1459570776000},"page":"271-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Vilazodone does not inhibit sexual behavior in male rats in contrast to paroxetine: A role for 5-HT1A receptors?"],"prefix":"10.1016","volume":"107","author":[{"given":"Ronald S.","family":"Oosting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny S.W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berend","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.03.045_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2004.09.009","article-title":"Effects of systemic injections of vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats","volume":"504","author":"Adamec","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib2","first-page":"276","article-title":"Effect of SR 59026A, a new 5-HT1A receptor agonist, on sexual activity in male rats","author":"Arnone","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejphar.2013.07.014","article-title":"Electrophysiological evidence for rapid 5-HT(1)A autoreceptor inhibition by vilazodone, a 5-HT(1)A receptor partial agonist and 5-HT reuptake inhibitor","volume":"714","author":"Ashby","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.curtheres.2005.04.006","article-title":"Antidepressant-related adverse effects impacting treatment compliance: results of a patient survey","volume":"66","author":"Ashton","year":"2005","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A\u00a0review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pbb.2013.10.004","article-title":"Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?","volume":"121","author":"Bijlsma","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1741-7015-9-90","article-title":"Cross-national epidemiology of DSM-IV major depressive episode","volume":"9","author":"Bromet","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib10","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/00001756-199905140-00010","article-title":"Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex","volume":"10","author":"Casanovas","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejphar.2008.02.098","article-title":"Translational research into sexual disorders: pharmacology and genomics","volume":"585","author":"Chan","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib12","first-page":"97","article-title":"The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats","volume":"8","author":"Chan","year":"2011","journal-title":"J.\u00a0Sex. Med."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0934s53","article-title":"Drug-induced sexual dysfunction in rats","author":"Chan","year":"2010","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib14","doi-asserted-by":"crossref","DOI":"10.2147\/NDT.S103408","article-title":"Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of 3 vilazodone studies","author":"Clayton","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/YIC.0000000000000075","article-title":"Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial","volume":"30","author":"Clayton","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib16","first-page":"2465","article-title":"The effect of vilazodone on sexual function during the treatment of major depressive disorder","volume":"10","author":"Clayton","year":"2013","journal-title":"J.\u00a0Sex. Med."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib17","first-page":"2465","article-title":"The effect of vilazodone on sexual function during the treatment of major depressive disorder","volume":"10","author":"Clayton","year":"2013","journal-title":"J.\u00a0Sex. Med."},{"issue":"Suppl.\u00a06","key":"10.1016\/j.neuropharm.2016.03.045_bib18","first-page":"33","article-title":"Major depressive disorder, antidepressants, and sexual dysfunction","volume":"67","author":"Clayton","year":"2006","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib19","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.neuroscience.2005.05.012","article-title":"Effects of chronic paroxetine pretreatment on (\u00b1)-8-hydroxy-2-(di-n-propyl-amino) tetralin induced c-fos expression following sexual behavior","volume":"134","author":"De Jong","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib20","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.bjp.0702510","article-title":"Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat","volume":"126","author":"Haj\u00f3s","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.v65n0712","article-title":"Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate","volume":"65","author":"Hu","year":"2004","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2005.01.018","article-title":"Neurochemical evaluation of the novel 5-HT1A receptor partial agonist\/serotonin reuptake inhibitor, vilazodone","volume":"510","author":"Hughes","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/JCP.0b013e31819c76e9","article-title":"Sexual dysfunction, depression, and the impact of antidepressants","volume":"29","author":"Kennedy","year":"2009","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-199906000-00012","article-title":"Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors","volume":"19","author":"Landen","year":"1999","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00176767","article-title":"Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine","volume":"352","author":"Le Poul","year":"1995","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0022-3565(24)36965-4","article-title":"A\u00a0desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors","volume":"282","author":"Li","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1021\/cn3000923","article-title":"The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics","volume":"3","author":"Lindsley","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/7854_2010_116","article-title":"Differences in sexual behaviour in male and female rodents: role of serotonin","volume":"8","author":"Olivier","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00213-015-4198-1","article-title":"Differential effects of vilazodone versus citalopram and paroxetine on sexual dysfunction and serotonin transporter and receptors in male rats","volume":"233","author":"Oosting","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib30","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/jpet.102.034280","article-title":"Behavioral and neurochemical effects of 5-{4-[4-(5-cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine1A receptor partial agonist","volume":"302","author":"Page","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1460-9568.2005.04252.x","article-title":"Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders","volume":"22","author":"Pattij","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0969-8051(00)00120-7","article-title":"Drug action at the 5-HT 1A receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-11 C] WAY-100635","volume":"27","author":"Rabiner","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib32","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1503\/jpn.130076","article-title":"Management strategies for SSRI-induced sexual dysfunction","volume":"38","author":"Rizvi","year":"2013","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00004714-199902000-00013","article-title":"Effects of SSRIs on sexual function: a critical review","volume":"19","author":"Rosen","year":"1999","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/JCP.0b013e3181a5233f","article-title":"Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis","volume":"29","author":"Serretti","year":"2009","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tips.2007.10.009","article-title":"Important messages in the \u2018post\u2019: recent discoveries in 5-HT neurone feedback control","volume":"28","author":"Sharp","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fpsyt.2012.00082","article-title":"Quetiapine and buspirone both elevate cortical levels of noradrenaline and dopamine in\u00a0vivo, but do not have synergistic effects","volume":"3","author":"Silverstone","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2014.09.003","article-title":"The role of adrenoceptors in the central nervous system in male and female rat sexual behavior","volume":"753","author":"Snoeren","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pbb.2013.11.007","article-title":"Serotonin 1A receptors and sexual behavior in male rats: a review","volume":"121","author":"Snoeren","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib39","first-page":"2547","article-title":"Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output","volume":"231","author":"van Amsterdam","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00213-001-0980-3","article-title":"The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment","volume":"160","author":"Waldinger","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.03.045_bib41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00004714-200112000-00003","article-title":"SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram","volume":"21","author":"Waldinger","year":"2001","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.03.045_bib42","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1124\/dmd.107.015768","article-title":"6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats","volume":"35","author":"Wong","year":"2007","journal-title":"Drug Metab. Dispos."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816301174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816301174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:42:28Z","timestamp":1748832148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816301174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":42,"alternative-id":["S0028390816301174"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.045","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vilazodone does not inhibit sexual behavior in male rats in contrast to paroxetine: A role for 5-HT1A receptors?","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}